Gender differences in the prospective associations of self-reported sleep quality with biomarkers of systemic inflammation and coagulation: Findings from the Heart and Soul Study

Journal of Psychiatric Research

Volumn 47, Issue 9, 2013, Pages 1228-1235

  Prather, Aric A ^a   Epel, Elissa S ^a   Cohen, Beth E ^a,c   Neylan, Thomas C ^a,c   Whooley, Mary A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Coronary heart disease; Gender; Inflammation; Sleep

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; FOLLOW UP; HEART FUNCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDER; SLEEP QUALITY; SOCIAL PSYCHOLOGY;

EID: 84880135371     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.05.004     Document Type: Article

References (57)

1. Ayas N.T., White D.P., Al-Delaimy W.K., Manson J.E., Stampfer M.J., Speizer F.E., et al. Aprospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003, 26:380-384.
2. Ayas N.T., White D.P., Manson J.E., Stampfer M.J., Speizer F.E., Malhotra A., et al. Aprospective study of sleep duration and coronary heart disease in women. Archives of Internal Medicine 2003, 163:205-209.
3. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., et al. Amechanism converting psychosocial stress into mononuclear cell activation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:1920-1925.
4. Bush A.L., Armento M.E.A., Weiss B.J., Rhoades H.M., Novy D.M., Wilson N.L., et al. The Pittsburgh sleep quality index in older primary care patients with generalized anxiety disorder: psychometrics and outcomes following cognitive behavioral therapy. Psychiatry Research 2012, 199:24-30.
5. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Research 1989, 28:193-213.
6. Cappuccio F.P., Stranges S., Kandala N.B., Miller M.A., Taggart F.M., Kumari M., et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II study. Hypertension 2007, 50:693-700.
7. Carpenter J.S., Andrykowski M.A. Psychometric evaluation of the pittsburgh sleep quality index. Journal of Psychosomatic Research 1998, 45:5-13.
8. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA: The Journal of the American Medical Association 1998, 279:1477-1482.
9. Deshpande R., Khalili H., Pergolizzi R.G., Michael S.D., Chang M.D. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. American Journal of Reproductive Immunology 1997, 38:46-54.
10. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Pickering T.G., et al. Short sleep duration as a risk factor for hypertension: analyses of the first national health and nutrition examination Survey. Hypertension 2006, 47:833-839.
11. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Pickering T.G., et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007, 30:1667-1673.
12. Gangwisch J.E., Malaspina D., Babiss L.A., Opler M.G., Posner K., Shen S., et al. Short sleep duration as a risk factor for hypercholesterolemia: analyses of the national longitudinal study of adolescent health. Sleep 2010, 33:956-961.
13. Gottlieb D.J., Redline S., Nieto F.J., Baldwin C.M., Newman A.B., Resnick H.E., et al. Association of usual sleep duration with hypertension: the sleep heart health study. Sleep 2006, 29:1009-1014.
14. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
15. Hall M.H., Muldoon M.F., Jennings J.R., Buysse D.J., Flory J.D., Manuck S.B. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 2008, 31:635-643.
16. Hong S., Mills P.J., Loredo J.S., Adler K.A., Dimsdale J.E. The association between interleukin-6, sleep, and demographic characteristics. Brain, Behavior, and Immunity 2005, 19:165-172.
17. Irwin M.R., Carrillo C., Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain, Behavior, and Immunity 2010, 24:54-57.
18. Irwin M., Clark C., Kennedy B., Christian Gillin J., Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain, Behavior, and Immunity 2003, 17:365-372.
19. Jones T.H., Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009, 207:318-327.
20. Kannel W.B., Wolf P.A., Castelli W.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA: The Journal of the American Medical Association 1987, 258:1183-1186.
21. Kapoor D., Clarke S., Stanworth R., Channer K.S., Jones T.H. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. European Journal of Endocrinology 2007, 156:595-602.
22. Leineweber C., Kecklund G., Janszky I., Akerstedt T., Orth-Gomer K. Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease. The Stockholm female coronary risk study. Journal of Psychosomatic Research 2003, 54:121-127.
23. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
24. Malkin C.J., Pugh P.J., Jones R.D., Kapoor D., Channer K.S., Jones T.H. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. The Journal of Clinical Endocrinology and Metabolism 2004, 89:3313-3318.
25. Mallon L., Broman J.E., Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. Journal of Internal Medicine 2002, 251:207-216.
26. Matthews K.A., Zheng H., Kravitz H.M., Sowers M., Bromberger J.T., Buysse D.J., et al. Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women?: study of women's health across the nation sleep study. Sleep 2010, 33:1649-1655.
27. Meier-Ewert H.K., Ridker P.M., Rifai N., Regan M.M., Price N.J., Dinges D.F., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. Journal of the American College of Cardiology 2004, 43:678-683.
28. Miller M.A. Association of inflammatory markers with cardiovascular risk and sleepiness. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine 2011, 7:S31-S33.
29. Miller M.A., Cappuccio F.P. Inflammation, sleep, obesity and cardiovascular disease. Current Vascular Pharmacology 2007, 5:93-102.
30. Miller M.A., Kandala N.B., Kivimaki M., Kumari M., Brunner E.J., Lowe G.D., et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 2009, 32:857-864.
31. Motivala S.J. Sleep and inflammation: psychoneuroimmunology in the context of cardiovascular disease. Annals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine 2011, 42:141-152.
32. Mullington J.M., Haack M., Toth M., Serrador J.M., Meier-Ewert H.K. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Progress in Cardiovascular Diseases 2009, 51:294-302.
33. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system. Brain, Behavior, and Immunity 1987-2007, 2007(21):736-745.
34. Newman A.B., Enright P.L., Manolio T.A., Haponik E.F., Wahl P.W. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the cardiovascular health study. Journal of the American Geriatrics Society 1997, 45:1-7.
35. Newman A.B., Spiekerman C.F., Enright P., Lefkowitz D., Manolio T., Reynolds C.F., et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. Journal of the American Geriatrics Society 2000, 48:115-123. The Cardiovascular Health Study Research Group.
36. O'Connor M.F., Motivala S.J., Valladares E.M., Olmstead R., Irwin M.R. Sex differences in monocyte expression of IL-6: role of autonomic mechanisms. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2007, 293:R145-R151.
37. Okun M.L., Coussons-Read M., Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Brain, Behavior, and Immunity 2009, 23:351-354.
38. Palesh O., Zeitzer J.M., Conrad A., Giese-Davis J., Mustian K.M., Popek V., et al. Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine 2008, 4:441-449.
39. Palmieri V., Celentano A., Roman M.J., de Simone G., Best L., Lewis M.R., et al. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the strong heart study. American Heart Journal 2003, 145:467-474.
40. Patel S.R., Zhu X., Storfer-Isser A., Mehra R., Jenny N.S., Tracy R., et al. Sleep duration and biomarkers of inflammation. Sleep 2009, 32:200-204.
41. Radloff L.S. The CES-D scale: a self-reort depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
42. Ray P., Ghosh S.K., Zhang D.H., Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Letters 1997, 409:79-85.
43. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England Journal of Medicine 2000, 342:836-843.
44. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
45. Ross R. Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999, 340:115-126.
46. Sarwar N., Thompson A.J., Di Angelantonio E. Markers of inflammation and risk of coronary heart disease. Disease Markers 2009, 26:217-225.
47. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. American Journal of Respiratory and Critical Care Medicine 2001, 163:19-25.
48. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
49. Simpson N., Dinges D.F. Sleep and inflammation. Nutrition Reviews 2007, 65:S244-S252.
50. Sloan R.P., McCreath H., Tracey K.J., Sidney S., Liu K., Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Molecular Medicine 2007, 13:178-184.
51. Stec J.J., Silbershatz H., Tofler G.H., Matheney T.H., Sutherland P., Lipinska I., et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation 2000, 102:1634-1638.
52. Suarez E.C. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain, Behavior, and Immunity 2008, 22:960-968.
53. Taheri S., Austin D., Lin L., Nieto F.J., Young T., Mignot E. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007, 30:991-996.
54. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. The Journal of Clinical Endocrinology and Metabolism 2004, 89:2119-2126.
55. Walsh B., Shiff I. Menopause. Principles and practice of endocrinology and metabolism 2001, 982-991. Lippincott, Williams & Wilkons, Philadelphia, PA. Becker (Ed.).
56. Whooley M.A., Caska C.M., Hendrickson B.E., Rourke M.A., Ho J., Ali S. Depression and inflammation in patients with coronary heart disease: findings from the heart and soul study. Biological Psychiatry 2007, 62:314-320.
57. Whooley M.A., de Jonge P., Vittinghoff E., Otte C., Moos R., Carney R.M., et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA: The Journal of the American Medical Association 2008, 300:2379-2388.